Protein C deficiency with recurrent systemic thrombosis associated with compound heterozygous PROC missense variants

Mikio Shiba1, Shuichiro Higo2, Yu Morishita2

  • 1Cardiovascular Division, Osaka Police Hospital, Osaka, Japan.

Insights

Compound heterozygous PROC variants were identified in a protein C deficient patient experiencing recurrent thrombotic events. These genetic variants impact protein C activity and secretion, contributing to severe thrombotic conditions.

Area of Science:

  • Genetics
  • Hematology
  • Molecular Biology

Background:

  • Protein C deficiency is a rare inherited thrombophilia.
  • Recurrent thrombotic events can be associated with genetic mutations affecting the Protein C gene (PROC).

Purpose of the Study:

  • To identify the genetic cause of protein C deficiency in a patient with severe thrombotic events.
  • To investigate the functional impact of identified PROC variants on protein C activity and secretion.

Main Methods:

  • Exome sequencing and Sanger sequencing were used to identify PROC variants.
  • Western blot analysis was performed on transfected cell lines to assess protein C expression and secretion.

Main Results:

  • Compound heterozygous missense variants (p.Val26Met and p.Gly334Ser) in the PROC gene were identified.
  • The p.Gly334Ser variant significantly decreased protein C expression in culture media, suggesting impaired secretion.
  • Protein C levels and activity were extremely low in the patient (<10% activity, <5% antigen).

Conclusions:

  • Compound heterozygous PROC variants contribute to severe protein C deficiency and recurrent thrombotic events.
  • The identified variants likely impair both protein C activity and its secretory process, leading to a prothrombotic state.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
592
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
679
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.8K
Probability Laws01:49

Probability Laws

Overview
39.6K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
176
Cohesins02:20

Cohesins

Cohesin protein complexes are a molecular glue that holds two sister chromatids together. They play an important role both in mitosis and meiosis. In mitosis, all cohesin complexes present on the chromosomes are removed before the start of the anaphase stage.
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
4.3K